Metric Finance
LearnFAQ
LearnFAQ

Learn / LQDA

NASDAQ: LQDA

Liquidia (LQDA) stock, explained like you're 5

Liquidia trades on the Nasdaq under the ticker LQDA. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.5 billion dollars.

Ticker
LQDA
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 2.5 billion dollars

Is Liquidia a small, medium or large cap company?

No. Liquidia is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.5 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Liquidia makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves LQDA stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Liquidia surges as United Therapeutics settlement removes key litigation risk (Reuters)
  • Patients with high blood pressure in the lungs will keep access to YUTREPIA as Liquidia settles six lawsuits. (Stock Titan)
  • Liquidia shares surge to 5 month high premarket on United Therapeutics settlement (Yahoo Finance)
  • How Much Downside Is Left In Liquidia Stock? (Trefis)
  • Liquidia And United Therapeutics Settle; But Only One Stock Skyrocketed (Investor's Business Daily)

Follow LQDA in your daily brief

Each trading day at 5 PM ET we post what happened to Liquidia and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow LQDA

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Liquidia stock

What does Liquidia do?

Liquidia trades on the Nasdaq under the ticker LQDA. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.5 billion dollars.

What is the ticker symbol for Liquidia?

Liquidia trades under the ticker LQDA on the Nasdaq.

What is Liquidia's market cap?

Liquidia is a mid cap stock with a market cap of about 2.5 billion dollars.

How does Liquidia make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves LQDA stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow LQDA stock every day?

Add LQDA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow LQDA daily

A free brief on Liquidia and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare LQDA: LQDA vs NVS, LQDA vs AZN, LQDA vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed